ATE67314T1 - Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen. - Google Patents

Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen.

Info

Publication number
ATE67314T1
ATE67314T1 AT86402610T AT86402610T ATE67314T1 AT E67314 T1 ATE67314 T1 AT E67314T1 AT 86402610 T AT86402610 T AT 86402610T AT 86402610 T AT86402610 T AT 86402610T AT E67314 T1 ATE67314 T1 AT E67314T1
Authority
AT
Austria
Prior art keywords
interferences
carbohydrates
prophylactic
viruses
diagnostic
Prior art date
Application number
AT86402610T
Other languages
English (en)
Inventor
A Gerard Quash
John Dennis Rodwell
Thomas Joseph Mckearn
Jean-Pierre Ripoll
Original Assignee
Inst Nat Sante Rech Med
Cytogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8517377A external-priority patent/FR2590674B1/fr
Application filed by Inst Nat Sante Rech Med, Cytogen Corp filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE67314T1 publication Critical patent/ATE67314T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT86402610T 1985-11-25 1986-11-25 Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen. ATE67314T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8517377A FR2590674B1 (fr) 1985-11-25 1985-11-25 Nouveaux reactifs de diagnostic
US06/928,631 US4853326A (en) 1985-11-25 1986-11-18 Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic prophylactic and/or therapeutic applications
EP86402610A EP0229546B1 (de) 1985-11-25 1986-11-25 Störungen von Karbohydraten in Viren oder Virusantigenen und Verwendung in diagnostischen, prophylaktischen und/oder therapeutischen Anwendungen

Publications (1)

Publication Number Publication Date
ATE67314T1 true ATE67314T1 (de) 1991-09-15

Family

ID=26224838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86402610T ATE67314T1 (de) 1985-11-25 1986-11-25 Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen.

Country Status (8)

Country Link
EP (1) EP0229546B1 (de)
AT (1) ATE67314T1 (de)
AU (1) AU592142B2 (de)
DE (1) DE3681428D1 (de)
ES (1) ES2038597T3 (de)
FI (1) FI873233A (de)
GR (1) GR3003323T3 (de)
WO (1) WO1987003206A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
EP0364492A1 (de) * 1987-06-30 1990-04-25 The Upjohn Company Virusproteine mit reduzierter o-glykosylierung
DE3884811T2 (de) * 1987-08-11 1994-02-24 Univ Minnesota Hyperimmun globulin gegen hiv.
US5164481A (en) * 1989-08-23 1992-11-17 Iaf Biochem International Inc. Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
US5427792A (en) * 1989-08-23 1995-06-27 Biochem Immunosystems, Inc. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
DE4025499A1 (de) * 1990-08-11 1992-02-13 Sandoz Ag Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen
EP2289547B1 (de) 2003-09-12 2015-12-16 Agenus Inc. Impfstoff zur Behandlung und Prävention der Herpes Simplex-Virusinfektion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2378094A2 (fr) * 1977-01-24 1978-08-18 Inst Nat Sante Rech Med Nouveaux reactifs biologiques constitues par des supports solides sur lesquels sont couples des composes organiques comportant un residu glucidique
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
JPS54113492A (en) * 1978-02-24 1979-09-05 Sanyo Chem Ind Ltd Preparation of glucoprotein derivative
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
EP0117657A1 (de) * 1983-02-01 1984-09-05 Genentech, Inc. Tollwut-immunogene Polypeptide und davon abgeleitetes Vakzin, DNA-Sequenzen, Expressionsvektoren, rekombinante Zellen und Kulturen dafür sowie Verfahren zu deren Herstellung
FR2543570B1 (fr) * 1983-03-31 1985-08-09 Pasteur Institut Anticorps monoclonaux anticytomegalovirus humains, hybridomes secreteurs de ces anticorps et polypeptides porteurs d'un determinant antigenique sequentiel de cytomegalovirus humains
WO1984004327A1 (en) 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
US4634666A (en) * 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus

Also Published As

Publication number Publication date
GR3003323T3 (en) 1993-02-17
FI873233A0 (fi) 1987-07-23
EP0229546A1 (de) 1987-07-22
WO1987003206A1 (en) 1987-06-04
FI873233A (fi) 1987-07-23
ES2038597T3 (es) 1993-08-01
AU6723187A (en) 1987-07-01
DE3681428D1 (de) 1991-10-17
EP0229546B1 (de) 1991-09-11
AU592142B2 (en) 1990-01-04

Similar Documents

Publication Publication Date Title
ZA868886B (en) Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic,prophylactic and/or therapeutic applications
DE68928119T2 (de) Non-A, non-B-Hepatitisvirus-Antigenpeptid
MX9203607A (es) Anticuerpo monoclonal que define un antigeno glicolipido asociado con carcinomas pulmonares en humanos, de celulas no pequeñas.
OA08485A (fr) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
ATE67314T1 (de) Stoerungen von karbohydraten in viren oder virusantigenen und verwendung in diagnostischen, prophylaktischen und/oder therapeutischen anwendungen.
CA2108259A1 (en) Process of screening plasma samples for effective antibody titers against respiratory viruses
DE69433378D1 (de) Humane b-lymphoblastoiden zellinie welche anti-gangliosid-antikörper sekretiert
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
ES8405952A1 (es) Un metodo de detectar un anticuerpo antivirus
DE69030545D1 (de) Aufspüren und Behandeln von Infektionen durch Verwendung von Immunokonjukaten
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
DE3850634D1 (de) Alpha 2-3-Verbindungen erkennender monoklonaler Antikörper.
ES2156858T3 (es) Reactivo de diagnostico para hepatitis c.
Jonsson et al. Immune complexes and complement components in Bell’s palsy
Julkunen et al. Elevated serum immune complex levels in Pogosta disease, an acute alphavirus infection with rash and arthritis.
SE9300139D0 (sv) Manufacture of a new drug
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
ATE108663T1 (de) Treponema hyodysenteriae-antigen und seine verwendungen.
SE9002671D0 (sv) Nya peptider, diagnostiska antigener, anvaendning daerav och vacciner
EP0183215A3 (en) Method for determination of herpes simplex virus antibodies
Ronneberger Assay of possible formation of antigenic components in heat-treated plasma protein preparations
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Oka Serum antibody titers of patients who had a positive test for the O-Ring(OR) reaction to a wide variety of viral infection
IL82563A0 (en) Carbohydrate perturbations of viruses or viral antigens and utilization for diagnostic,prophylactic and/or therapeutic applications
IL73281A0 (en) Purified antigen isolated from sera of leukemia and lymphoma patients,novel antibodies to said antigen,methods of preparing same and diagnostic and therapeutic methods employing said antibody

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee